Retatrutide, by Soma, represents a significant advance in body regulation. This dual-action medication combines hormonal receptor agonist properties with GIP pathway engagement, indicating impressive efficacy in patient findings for metabolic reduction . Researchers believe the drug is expected to provide a new solution for patients experiencing… Read More